![](https://pmlive.com/wp-content/uploads/2024/02/Leo_-_Offices_cropped.jpg)
LEO Pharma’s delgocitinib cream shows promise in phase 3 chronic hand eczema trials
LEO Pharma’s investigational JAK-inhibitor cream has demonstrated improvements in chronic hand eczema (CHE), according to late-stage results recently published in The Lancet. Hand eczema (HE) is the most common skin disorder of the hands and CHE, which …